Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Kreienberg R, Albert US, Follmann M, Kopp IB, Kühn T, Wöckel A.

Geburtshilfe Frauenheilkd. 2013 Jun;73(6):556-583. No abstract available.

PMID:
24771925
[PubMed]
Free PMC Article
2.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; “FOLLOW-UP” Study Group.

PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.

PMID:
24714591
[PubMed - in process]
Free PMC Article
3.

Quality of cancer follow-up care: a focus on Latina breast cancer survivors.

Rosales M, Ashing K, Napoles A.

J Cancer Surviv. 2014 Sep;8(3):364-71. doi: 10.1007/s11764-014-0343-9. Epub 2014 Feb 22.

PMID:
24563169
[PubMed - in process]
Free PMC Article
4.

Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.

Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):946-61. doi: 10.1158/1055-9965.EPI-12-1208-T. Epub 2013 Mar 19.

PMID:
23513042
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients.

Mallmann MR, Staratschek-Jox A, Rudlowski C, Braun M, Gaarz A, Wolfgarten M, Kuhn W, Schultze JL.

EPMA J. 2010 Sep;1(3):421-37. doi: 10.1007/s13167-010-0044-z. Epub 2010 Aug 20.

PMID:
23199086
[PubMed]
Free PMC Article
6.

Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator.

Wills S, Ravipati A, Venuturumilli P, Kresge C, Folkerd E, Dowsett M, Hayes DF, Decker DA.

J Oncol Pract. 2012 May;8(3):144-8. doi: 10.1200/JOP.2011.000352. Epub 2012 Feb 7.

PMID:
22942807
[PubMed]
Free PMC Article
7.

Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.

Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DS, Geller BM, Muss HB, Irwig L.

JAMA. 2011 Feb 23;305(8):790-9. doi: 10.1001/jama.2011.188.

PMID:
21343578
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.

Rae JM, Sikora MJ, Henry NL, Li L, Kim S, Oesterreich S, Skaar TC, Nguyen AT, Desta Z, Storniolo AM, Flockhart DA, Hayes DF, Stearns V; COBRA investigators.

Pharmacogenomics J. 2009 Aug;9(4):258-64. doi: 10.1038/tpj.2009.14. Epub 2009 May 5.

PMID:
19421167
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

Gianni L, Gelber S, Ravaioli A, Price KN, Panzini I, Fantini M, Castiglione-Gertsch M, Pagani O, Simoncini E, Gelber RD, Coates AS, Goldhirsch A.

Eur J Cancer. 2009 Mar;45(4):561-71. doi: 10.1016/j.ejca.2008.10.011. Epub 2008 Dec 4.

PMID:
19062268
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk